Comparison of the efficacy of prophylaxis with Pregabalin and Sodium Valproate on intensity and frequency of migraine type headache in Iranian patients

Trial Profile

Comparison of the efficacy of prophylaxis with Pregabalin and Sodium Valproate on intensity and frequency of migraine type headache in Iranian patients

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Pregabalin (Primary) ; Sodium valproate
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Mar 2014 Status changed from recruiting to active, no longer recruiting, as per Iranian Registry of Clinical Trials record.
    • 13 May 2013 Recruitment expected to complete on 20 Jan 2014.
    • 13 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top